The alcohol and starch/sugar enzyme market is projected to be worth $2,238.4 million by 2018 and is expected to grow at a CAGR of 7.9% from 2013 to 2018.
North America is the largest market for the demand of starch/sugar enzymes, with the U.S. commanding a major share of the market. Rising concerns on health care and cosmetics lead to the demand of pharmaceuticals in drugs and cosmetics. North America is one of the largest segments for the use of starch/sugar enzymes. The demand for starch/sugar enzymes has increased in recent years, due to the introduction of new drugs used in enzyme replacement therapy. The increasing use of biofuels is one of the major drivers for the starch/sugar enzyme market.